Skip to main content
Clinical Trials/JPRN-UMIN000014850
JPRN-UMIN000014850
Completed
未知

Comprehensive Analysis of Disease-Related Genes associated with Non-alcoholic Fatty Liver Disease (NAFLD)/ Non-Alcoholic Steatohepatitis (NASH); Study of Associations among the Disease-Related Genes and Serum Biomarkers and the Degree of Progression of NAFLD/NASH Pathology - Comprehensive Analysis of Disease-Related Genes associated with NAFLD/NASH; Study of Associations among the Disease-Related Genes and Serum Biomarkers and the Degree of Progression of NAFLD/NASH Pathology

ational Center for Global Health and Medicine, Department of Gastroenterology Kohnodai Hospital, Department of Gastroenterology The Research Center for Hepatitis and Immunology0 sites308 target enrollmentDecember 1, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
on-alcoholic Fatty Liver Disease/ Non-alcoholic Steatohepatitis
Sponsor
ational Center for Global Health and Medicine, Department of Gastroenterology Kohnodai Hospital, Department of Gastroenterology The Research Center for Hepatitis and Immunology
Enrollment
308
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2014
End Date
March 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Center for Global Health and Medicine, Department of Gastroenterology Kohnodai Hospital, Department of Gastroenterology The Research Center for Hepatitis and Immunology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a.Patients who have any other liver disease, such as chronic hepatitis C, chronic hepatitis B (HBs\-Ag\-positive patients), autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, alpha 1\-antitrypsin deficiency, Wilson disease, or alcohol\-related liver disease b.Patients who have a serious hepatic dysfunction, liver failure (encephalopathy, ascites, ruptured varices, or hyperbilirubinemia) c.Patients who have a serious renal dysfunction d.Patients who have a serious cardiopulmonary dysfunction e.Pregnant women, parturient women, breast\-feeding women

Outcomes

Primary Outcomes

Not specified

Similar Trials